Nutrition
Volume 24, Issue 4 , Pages 382-389 , April 2008

Nutritional factors and polyamine metabolism in colorectal cancer

Received 5 July 2007 ,Accepted 19 December 2007.

References 

  1. Jass JR, Whitehall VL, Young J, Leggett BA. Emerging concepts in colorectal neoplasia. Gastroenterology. 2002;123:862–876
  2. Gonzalez CA. The European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr. 2006;9:124–126
  3. Kelly KM, Dickinson SL, Degraffinreid CR, Tatum CM, Paskett ED. Colorectal cancer screening in 3 racial groups. Am J Health Behav. 2007;31:502–513
  4. Asano T, McLeod RS. Dietary fibre for the prevention of colorectal adenomas and carcinomas. Cochrane Database Syst Rev. 2002;2:CD003430
  5. Delmonte P, Rader JI. Analysis of isoflavones in foods and dietary supplements. J AOAC Int. 2006;89:1138–1146
  6. Hallmans G, Zhang JX, Lundin E, Stattin P, Johansson A, Johansson I, et al. Rye, lignans and human health. Proc Nutr Soc. 2003;62:193–199
  7. Touillaud MS, Thiébaut AC, Fournier A, Niravong M, Boutron-Ruault MC, Clavel-Chapelon F. Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status. J Natl Cancer Inst. 2007;99:475–486
  8. Cotterchio M, Boucher BA, Manno M, Gallinger S, Okey A, Harper P. Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. J Nutr. 2006;136:3046–3053
  9. Lechner D, Kallay E, Cross HS. Phytoestrogens and colorectal cancer prevention. Vitam Horm. 2005;70:169–198
  10. Linsalata M, Messa C, Russo F, Cavallini A, Di Leo A. Estrogen receptors and polyamine levels in human gastric carcinoma. Scand J Gastroenterol. 1994;29:67–70
  11. Russo F, Linsalata M, Messa C, Cavallini A, Notarnicola M, Guerra V, et al. Polyamines and estrogen receptor concentrations in human colorectal carcinomas. Ital J Gastroenterol. 1992;24:8–12
  12. Di Leo A, Messa C, Russo F, Misciagna G, Guerra V, Taveri R, et al. Prognostic value of cytosolic estrogen receptors in human colorectal carcinoma and surrounding mucosa: preliminary results. Dig Dis Sci. 1994;39:2038–2042
  13. Cross HS, Kallay E, Lechner D, Gerdenitsch W, Adlercreutz H, Armbrecht HJ. Phytoestrogens and vitamin D metabolism: a new concept for the prevention and therapy of colorectal, prostate, and mammary carcinomas. J Nutr. 2004;134:1207S–1212S
  14. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997;275:218–220
  15. Signorelli P, Ghidoni R. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem. 2005;16:449–466
  16. Rush JW, Quadrilatero J, Levy AS, Ford RJ. Chronic resveratrol enhances endothelium-dependent relaxation but does not alter eNOS levels in aorta of spontaneously hypertensive rats. Exp Biol Med (Maywood). 2007;232:814–822
  17. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 2004;24:2783–2840
  18. Geier MS, Butler RN, Howarth GS. Probiotics, prebiotics and synbiotics: a role in chemoprevention for colorectal cancer?. Cancer Biol Ther. 2006;5:1265–1269
  19. Fooks LJ, Gibson GR. Probiotics as modulators of the gut flora. Br J Nutr. 2002;88:S39–S49
  20. Ishikawa H, Akedo I, Otani T, Suzuki T, Nakamura T, Takeyama I, et al. Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int J Cancer. 2005;116:762–767
  21. Martin KR. Targeting apoptosis with dietary bioactive agents. Exp Biol Med (Maywood). 2006;231:117–129
  22. Nishioka K. Polyamines in cancer: basic mechanisms and clinical approaches. Georgetown: R.G. Landes Company; 1997;
  23. Choen SS. A guide to polyamines. New York: Oxford University Press; 1998;
  24. Thomas T, Thomas TJ. Polyamines in cell growth and cell death: molecular mechanisms and therapeutic application. Cell Mol Life Sci. 2001;58:244–258
  25. Rothenburg S, Koch-Nolte F, Rich A, Haag F. A polymorphic dinucleotide repeat in the rat nucleolin gene forms Z-DNA and inhibits promoter activity. Proc Natl Acad Sci U S A. 2001;98:8985–8990
  26. Shah N, Thomas TJ, Lewis JS, Klinge CM, Shirahata A, Gelinas C, et al. Regulation of estrogenic and nuclear factor kB functions by polyamines and their role in polyamine analog-induced apoptosis of breast cancer cells. Oncogene. 2001;20:1715–1729
  27. Morgan DML. Polyamines, An overview. Mol Biotechnol. 1999;11:229–250
  28. Seiler N. How important is the oxidative degradation of spermine?: Minireview article. Amino Acids. 2004;26:317–319
  29. Moinard C, Cynober L, de Bandt JP. Polyamines: metabolism and implications in human diseases. Clin Nutr. 2005;24:184–197
  30. Igarashi K, Kashiwagri K. Polyamines: mysterious modulators of cellular functions. Biochem Biophys Res Commun. 2000;271:559–564
  31. Wallace HM, Caslake R. Polyamines and colon cancer. Eur J Gastroenterol Hepatol. 2001;13:1033–1039
  32. Thomas T, Thomas TJ. Polyamine metabolism and cancer. J Cell Mol Med. 2003;7:113–126
  33. Seiler N, Raul F. Polyamines and apoptosis. J Cell Mol Med. 2005;9:623–642
  34. Gerner EW, Meyskens FL. Polyamines and cancer: old molecules, new understanding. Natl Rev Cancer. 2004;4:781–792
  35. Linsalata M, Russo F, Cavallini A, Berloco P, Di Leo A. Polyamines, diamine oxidase, and ornithine decarboxylase activity in colorectal cancer and in normal surrounding mucosa. Dis Colon Rectum. 1993;36:662–667
  36. Shantz LM, Levin VA. Regulation of ornithine decarboxylase during oncogenic transformation: mechanisms and therapeutic potential. Amino Acids. 2007;33:213–223
  37. Linsalata M, Cavallini A, Di Leo A. Polyamine oxidase activity and polyamine levels in human colorectal cancer and in normal surrounding mucosa. Anticancer Res. 1997;17:3757–3760
  38. Linsalata M, Giannini R, Notarnicola M, Cavallini A. Peroxisome proliferator-activated receptor gamma and spermine/spermidine N1-acetyltransferase gene expression are significantly correlated in human colorectal cancer. BMC Cancer. 2006;6:191–197
  39. Erdman SH, Ignatenko NA, Powell MB, Blohm-Mangone KA, Holubec H, Guillen-Rodriguez JM, et al. APC-dependent changes in expression of genes influencing polyamine metabolism, and consequences for gastrointestinal carcinogenesis, in the Min mouse. Carcinogenesis. 1999;20:1709–1713
  40. Nilsson JA, Keller UB, Baudino TA, Yang C, Norton S, Old JA, et al. Targeting ornithine decarboxylase in Myc induced lymphomagenesis prevents tumor formation. Cancer Cell. 2005;7:433–434
  41. Tabib A, Bachrach U. Role of polyamines in mediating malignant transformation and oncogene expression. Int J Biochem Cell Biol. 1999;31:1289–1295
  42. Linsalata M, Notarnicola M, Caruso MG, Di Leo A, Guerra V, Russo F. Polyamine biosynthesis in relation to K-ras and p-53 mutations in colorectal carcinoma. Scand J Gastroenterol. 2004;39:470–477
  43. Notarnicola M, Linsalata M, Caruso MG, Caruso ML, Altomare D, Lorusso D, et al. Genetic and biochemical changes in colorectal carcinoma in relation to morphologic characteristics. Oncol Rep. 2003;10:1987–1991
  44. Milovic V, Turchanova L. Polyamines and colon cancer. Biochem Soc Trans. 2003;31:381–383
  45. Linsalata M, Caruso MG, Leo S, Guerra V, D’Attoma B, Di Leo A. Prognostic value of tissue polyamine levels in human colorectal carcinoma. Anticancer Res. 2002;22:2465–2470
  46. Linsalata M, Leo S, Guerra V, Di Leo A. Erythrocyte polyamines and prognosis in colorectal cancer patients. Anticancer Res. 2000;20:2113–2118
  47. Bachrach U. Polyamines and cancer: minireview article. Amino Acids. 2004;26:307–309
  48. Kawakita M, Hiramatsu K. Diacetylated derivatives of spermine and spermidine as novel promising tumour markers. J Biochem. 2006;139:315–322
  49. Enjoji M, Nakamuta M, Arimura E, Morizono S, Kuniyoshi M, Fukushima M, et al. Clinical significance of urinary N1, N12-diacetylspermine levels in patients with hepatocellular carcinoma. Int J Biol Markers. 2004;19:322–327
  50. Wallace HM, Fraser AV. Inhibitors of polyamine metabolism: review article. Amino Acids. 2004;26:353–365
  51. Seiler N. Thirty years of polyamine-related approaches to cancer therapy (Retrospect and prospect. Part 1. Selective enzyme inhibitors). Curr Drug Targets. 2003;4:537–564
  52. Cipolla BG, Havouis R, Moulinoux JP. Polyamine contents in current foods: a basis for polyamine reduced diet and study of its long term observance and tolerance in prostate carcinoma patients. Amino Acids. 2007;33:203–212
  53. Wallace HM, Niiranen K. Polyamine analogues—an update. Amino Acids. 2007;33:261–265
  54. Abeloff MD, Rosen ST, Luk GD, Baylin SB, Zeltzman M, Sjoerdsma A. Phase II trials of -difluoromethylornithine, an inhibitor of polyamine synthesis, in advanced small cell lung cancer and colon cancer. Cancer Treat Rep. 1986;70:843–845
  55. Meyskens FL, Gerner EW, Emerson S, Pelot D, Durbin T, Doyle K, et al. Effect of alpha-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention. J Natl Cancer Inst. 1998;90:1212–1218
  56. Lawson KR, Ignatenko NA, Piazza GA, Cui H, Gerner EW. Influence of K-ras activation on the survival responses of Caco-2 cells to the chemopreventive agents sulindac and difluoromethylornithine. Cancer Epidemiol Biomark Prev. 2000;9:1155–1162
  57. Lii H, Schut HA, Conran P, Kramer PM, Lubet RA, Steele VE, et al. Prevention by aspirin and its combination with alpha-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon. Carcinogenesis. 1999;20:425–430
  58. Babbar N, Ignatenko NA, Casero RA, Gerner EW. Cyclooxygenase-independent induction of apoptosis by sulindac sulfone is mediated by polyamines in colon cancer. J Biol Chem. 2003;278:47762–47775
  59. Babbar N, Gerner EW, Casero RJ. Induction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cells. Biochem J. 2006;394:317–324
  60. Gerner EW, Meyskens FL, Goldschmid S, Lance P, Pelot D. Rationale for, and design of, a clinical trial targeting polyamine metabolism for colon cancer chemoprevention. Amino Acids. 2007;33:189–195
  61. Moon YJ, Wang X, Morris ME. Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol In Vitro. 2006;20:187–210
  62. Tamaka T, Makita H, Kawabata K, Mori H, Kakumoto M, Satoh K, et al. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis. 1997;18:957–965
  63. Au A, Li B, Wang W, Roy H, Koehler K, Birt D. Effects of dietary apigenin on colonic ornithine decarboxylase activity, aberrant crypt foci formation, and tumorigenesis in different experimental models. Nutr Cancer. 2006;54:243–251
  64. Cassidy A. Potential risks and benefits of phytoestrogen-rich diets. Int J Vitam Nutr Res. 2003;73:120–126
  65. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol. 2002;3:364–373
  66. Cotterchio M, Boucher BA, Manno M, Gallinger S, Okey A, Harper P. Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. J Nutr. 2006;136:3046–3053
  67. Booth C, Hargreaves DF, Hadfield JA, McGown AT, Potten CS. Isoflavones inhibit intestinal epithelial cell proliferation and induce apoptosis in vitro. Br J Cancer. 1999;80:1550–1557
  68. Ravindranath MH, Muthugounder S, Presser N, Viswanathan S. Anticancer therapeutic potential of soy isoflavone, genistein. Adv Exp Med Biol. 2004;546:121–165
  69. Hawrylewiez EJ, Zapata JJ, Blair WH. Soy and experimental cancer: animal studies. J Nutr. 1995;125:698S–708S
  70. Shon YH, Park SD, Nam KS. Effective chemopreventive activity of genistein against human breast cancer cells. J Biochem Mol Biol. 2006;39:448–451
  71. Linsalata M, Russo F, Notarnicola M, Guerra V, Cavallini A, Clemente C, et al. Effects of genistein on the polyamine metabolism and cell growth in DLD-1 human colon cancer cells. Nutr Cancer. 2005;52:83–92
  72. Sengottuvelan M, Senthilkurmar R, Nalini N. Modulatory influence of dietary resveratrol during different phases of 1,2-dimethylhydrazine induced mucosal lipid-peroxidation, antioxidant status and aberrant crypt foci development in rat colon carcinogenesis. Biochim Biophys Acta. 2006;1760:1175–1183
  73. Wolter F, Stein J. Resveratrol enhances the differentiation induced by butyrate in Caco-2 colon cancer cells. J Nutr. 2002;132:298–302
  74. Schneider Y, Vincent F, Duranton B, Badolo L, Gosse F, Bergmann C, et al. Anti-proliferative effects of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Lett. 2000;158:85–91
  75. Schneider Y, Duranton B, Gosse F, Scheiffer R, Seiler R, Raul F. Resveratrol inhibits intestinal tumorigenesis and modulates host–defense-related gene expression in an animal model of human familial adenomatous polyposis. Nutr Cancer. 2001;39:102–107
  76. Wolter F, Turchanova L, Stein J. Resveratrol-induced modification of polyamine metabolism is accompanied by induction of c-Fos. Carcinogenesis. 2003;24:469–474
  77. Ulrich S, Loitsch SM, Rau O, Von Knethen A, Brune B, Schubert-Zsilavecz M, et al. Peroxisome proliferator-activated receptor gamma as a molecular target of resveratrol-induced modulation of polyamine metabolism. Cancer Res. 2006;66:7348–7354
  78. Wallace HM, Faser AV, Hughes A. A perspective of polyamine metabolism. Biochem J. 2003;376:1–14
  79. Wolter F, Ulrich S, Stein J. Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in colorectal cancer: key role of polyamines?. J Nutr. 2004;134:3219–3222
  80. Das D, Arber N, Jankowski JA. Chemoprevention of colorectal cancer. Digestion. 2007;76:51–67
  81. Lin DC. Probiotics as functional foods. Nutr Clin Pract. 2003;18:497–506
  82. Wollowski I, Rechkemmer G, Pool-Zobel BL. Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr. 2001;73(suppl):451S–455S
  83. Reddy BS. Possible mechanisms by which pro- and prebiotics influence colon carcinogenesis and tumor growth. J Nutr. 1999;129:1478S–1482S
  84. Di Marzio L, Russo FP, D’Alò S, Biordi L, Ulisse S, Amicosante G, et al. Apoptotic effects of selected strains of lactic acid bacteria on a human T leukaemia cell line are associated with bacterial arginine deiminase and/or sphigomyelinase activities. Nutr Cancer. 2001;40:185–196
  85. Linsalata M, Russo F, Berloco P, Caruso ML, Di Matteo G, Cifone MG, et al. The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori-infected gastric mucosa. Helicobacter. 2004;9:165–172
  86. Russo F, Orlando A, Linsalata M, Cavallini A, Messa C. Effects of Lactobacillus rhamnosus GG on the cell growth and polyamine metabolism in HGC-27 human gastric cancer cells. Nutr Cancer. 2007;59:106–114
  87. Singh J, Rivenson A, Tomita M, Shimamura S, Ishibashi N, Reddy BS. Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis. 1997;18:833–841
  88. Linsalata M, Russo F, Berloco P, Valentini AM, Caruso ML, De Simone C, et al. Effects of probiotic bacteria (VSL#3) on the polyamine biosynthesis and cell proliferation of normal colonic mucosa of rats. In Vivo. 2005;19:989–996

PII: S0899-9007(07)00391-7

doi: 10.1016/j.nut.2007.12.014

Nutrition
Volume 24, Issue 4 , Pages 382-389 , April 2008

Article Tools

* Image Usage & Resolution